Singapore Cancer Network (SCAN) Guidelines for the Management of Advanced Castrate-Resistant Prostate Cancer

    Abstract

    Insights

    Singapore Cancer Network (SCAN) developed adapted clinical practice guidelines for advanced castrate-resistant prostate cancer management. These guidelines integrate international evidence for local application, improving patient care.

    Area of Science:

    • Oncology
    • Urology
    • Clinical Practice Guidelines

    Background:

    • The Singapore Cancer Network (SCAN) genitourinary cancer workgroup addressed the need for localized management strategies.
    • Advanced castrate-resistant prostate cancer requires evidence-based treatment protocols.

    Purpose of the Study:

    • To develop Singapore Cancer Network (SCAN) clinical practice guidelines for advanced castrate-resistant prostate cancer.
    • To adapt high-quality international evidence-based guidelines for the local Singaporean context.

    Main Methods:

    • A modified ADAPTE process was employed to systematically evaluate existing international guidelines.
    • Five key international guidelines from reputable organizations were assessed.

    Main Results:

    • Recommendations for managing advanced castrate-resistant prostate cancer were formulated based on the evaluated evidence.
    • The process ensured the calibration of international best practices to local healthcare needs.

    Conclusions:

    • The adapted guidelines were published as the SCAN Guidelines 2015.
    • These guidelines provide a framework for optimal patient management in Singapore.

    Related Concept Videos